These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 18084669)

  • 21. 111In-pentetreotide scintigraphy in the detection of insulinomas: importance of SPECT imaging.
    Schillaci O; Massa R; Scopinaro F
    J Nucl Med; 2000 Mar; 41(3):459-62. PubMed ID: 10716319
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnostic imaging approach to gastro-entero-pancreatic carcinomas of neuroendocrine origin - single NET center experience in Poland.
    Cwikla JB; Nasierowska-Guttmejer A; Jeziorski KG; Cichocki A; Zgliczynski W; Stepień K; Seklecka N; Durlik M; Malkowski B; Walecki J
    Neuro Endocrinol Lett; 2007 Dec; 28(6):789-800. PubMed ID: 18063942
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Pre- and intraoperative localization of neuroendocrine tumors].
    Adams S; Baum RP; Adams M; Wenisch H; Schumm-Draeger PM; Encke A; Usadel KH; Hör G
    Acta Med Austriaca; 1997; 24(2):81-6. PubMed ID: 9273812
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Can fluorodihydroxyphenylalanine PET replace somatostatin receptor scintigraphy in patients with digestive endocrine tumors?
    Montravers F; Grahek D; Kerrou K; Ruszniewski P; de Beco V; Aide N; Gutman F; Grangé JD; Lotz JP; Talbot JN
    J Nucl Med; 2006 Sep; 47(9):1455-62. PubMed ID: 16954553
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 111In-Pentetreotide SPECT/CT in Pulmonary Carcinoid.
    Chiaravalloti A; Spanu A; Danieli R; Dore F; Piras B; Falchi A; Tavolozza M; Madeddu G; Schillaci O
    Anticancer Res; 2015 Jul; 35(7):4265-70. PubMed ID: 26124388
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Receptor scintigraphy using 111In-pentetreotide in endocrine gastroenteropancreatic tumors].
    Joseph K; Stapp J; Reinecke J; Skamel HJ; Höffken H; Benning R; Neuhaus C; Lenze H; Trautmann ME; Arnold R
    Nuklearmedizin; 1993 Dec; 32(6):299-305. PubMed ID: 7905200
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Value of Somatostatin Receptor Scintigraphy (SRS) in Patients with NETG1/G2 Pancreatic Neuroendocrine Neoplasms (p-NENs).
    Kolasińska-Ćwikła AD; Konsek SJ; Buscombe JR; Maciejkiewicz K; Cichocki A; Roszkowska-Purska K; Sawicki Ł; Tenderenda M; Cwikla JB
    Nucl Med Rev Cent East Eur; 2019; 22(1):1-7. PubMed ID: 30276787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Whole body and tomographic scan with 111In-pentetreotide: preliminary data.
    Gregianin M; Macrì C; Bui F; Varotto L; Zucchetta P
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):124-6. PubMed ID: 9002769
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Incremental diagnostic value and impact on patient management of somatostatin receptor scintigraphy with indium-111-pentetreotide in gastroenteropancreatic neuroendocrine tumors.
    Usmani S; Khan HA; Abdulla M; Ahmed N; abu Huda F; Marafi F; al Kandari F; al Mohannadi S; al Nafisi N
    Med Princ Pract; 2011; 20(4):356-61. PubMed ID: 21576997
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
    Anderson CJ; Dehdashti F; Cutler PD; Schwarz SW; Laforest R; Bass LA; Lewis JS; McCarthy DW
    J Nucl Med; 2001 Feb; 42(2):213-21. PubMed ID: 11216519
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Factors predicting tracer uptake in somatostatin receptor and MIBG scintigraphy of metastatic gastroenteropancreatic neuroendocrine tumors.
    Ezziddin S; Logvinski T; Yong-Hing C; Ahmadzadehfar H; Fischer HP; Palmedo H; Bucerius J; Reinhardt MJ; Biersack HJ
    J Nucl Med; 2006 Feb; 47(2):223-33. PubMed ID: 16455627
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Morphological imaging in the localization of neuroendocrine gastroenteropancreatic tumors found by somatostatin receptor scintigraphy.
    Saga T; Shimatsu A; Koizumi K; Ichikawa T; Yamamoto K; Noguchi S; Doi R; Ishibashi M; Machinami R; Nakamura K; Sakahara H; Endo K
    Acta Radiol; 2005 May; 46(3):227-32. PubMed ID: 15981717
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Single photon emission computerized tomography increases the sensitivity of indium-111-pentetreotide scintigraphy in detecting abdominal carcinoids.
    Schillaci O; Scopinaro F; Danieli R; Angeletti S; Tavolaro R; Annibale B; Cannas P; Marignani M; Colella AC; Delle Fave G
    Anticancer Res; 1997; 17(3B):1753-6. PubMed ID: 9179229
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of metabolic and receptor imaging in recurrent medullary thyroid carcinoma with histopathological findings.
    Adams S; Baum RP; Hertel A; Schumm-Draeger PM; Usadel KH; Hör G
    Eur J Nucl Med; 1998 Sep; 25(9):1277-83. PubMed ID: 9724377
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Somatostatin receptor scintigraphy of malignant somatostatinoma with indium-111-pentetreotide.
    Schillaci O; Annibale B; Scopinaro F; delle Fave G; Colella AC
    J Nucl Med; 1997 Jun; 38(6):886-7. PubMed ID: 9189135
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Contribution of ¹¹¹In-pentetreotide SPECT/CT imaging to conventional somatostatin receptor scintigraphy in the detection of neuroendocrine tumours.
    Sainz-Esteban A; Olmos R; González-Sagrado M; González ML; Ruiz MÁ; García-Talavera P; Gamazo C; Villanueva JG; Cobo A; de Luis D
    Nucl Med Commun; 2015 Mar; 36(3):251-9. PubMed ID: 25369750
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preoperative localization of gastrointestinal endocrine tumors using somatostatin-receptor scintigraphy.
    Weinel RJ; Neuhaus C; Stapp J; Klotter HJ; Trautmann ME; Joseph K; Arnold R; Rothmund M
    Ann Surg; 1993 Nov; 218(5):640-5. PubMed ID: 7902072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of somatostatin analog and meta-iodobenzylguanidine radionuclides in the diagnosis and localization of advanced neuroendocrine tumors.
    Kaltsas G; Korbonits M; Heintz E; Mukherjee JJ; Jenkins PJ; Chew SL; Reznek R; Monson JP; Besser GM; Foley R; Britton KE; Grossman AB
    J Clin Endocrinol Metab; 2001 Feb; 86(2):895-902. PubMed ID: 11158063
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.